Cardiometabolic Medical Specialist openings??

Quote
anonymous said:
What isn't true?

1. Praluent is dead. Revenues are below $20MM. Is this what a few billion dollars of investment ROI looks like?

2. The US State Court of Delaware indicated more than one patent violations on Praluent. Fact.

3. Fourier data failed to impress. Fact.

4. Dupi now embattled in court as well.

5. List of patent fails from Eylea, to Praluent, to genetic mice.

6. Leadership failed every product launch except Eylea (this is being kind).

About talent,

1. REGN HR group acknowledged poor recruiting practices and retention. Fact. HR told me this.

2. Before, during, post happy hours and sometimes at work, HR (among other functions) provides "lip service" to management - usually senior. HR knows this and allows it. Head of HR said this.

3. This company shows no respect for anything outside of ideas (patents), biologic science / substance - Len S. said this along with George Y.

Most of the posts here deal with topics mentioned above...so what isn't true? I know due to my 14 year tenure.

99% of posts here are true.
Click to expand...
 






anonymous said:
What isn't true?

1. Praluent is dead. Revenues are below $20MM. Is this what a few billion dollars of investment ROI looks like?

2. The US State Court of Delaware indicated more than one patent violations on Praluent. Fact.

3. Fourier data failed to impress. Fact.

4. Dupi now embattled in court as well.

5. List of patent fails from Eylea, to Praluent, to genetic mice.

6. Leadership failed every product launch except Eylea (this is being kind).

About talent,

1. REGN HR group acknowledged poor recruiting practices and retention. Fact. HR told me this.

2. Before, during, post happy hours and sometimes at work, HR (among other functions) provides "lip service" to management - usually senior. HR knows this and allows it. Head of HR said this.

3. This company shows no respect for anything outside of ideas (patents), biologic science / substance - Len S. said this along with George Y.

Most of the posts here deal with topics mentioned above...so what isn't true? I know due to my 14 year tenure.

99% of posts here are true.
Click to expand...
 






anonymous said:
What isn't true?

1. Praluent is dead. Revenues are below $20MM. Is this what a few billion dollars of investment ROI looks like?

2. The US State Court of Delaware indicated more than one patent violations on Praluent. Fact.

3. Fourier data failed to impress. Fact.

4. Dupi now embattled in court as well.

5. List of patent fails from Eylea, to Praluent, to genetic mice.

6. Leadership failed every product launch except Eylea (this is being kind).

About talent,

1. REGN HR group acknowledged poor recruiting practices and retention. Fact. HR told me this.

2. Before, during, post happy hours and sometimes at work, HR (among other functions) provides "lip service" to management - usually senior. HR knows this and allows it. Head of HR said this.

3. This company shows no respect for anything outside of ideas (patents), biologic science / substance - Len S. said this along with George Y.

Most of the posts here deal with topics mentioned above...so what isn't true? I know due to my 14 year tenure.

99% of posts here are true.
Click to expand...
 






anonymous said:
What isn't true?

1. Praluent is dead. Revenues are below $20MM. Is this what a few billion dollars of investment ROI looks like?

2. The US State Court of Delaware indicated more than one patent violations on Praluent. Fact.

3. Fourier data failed to impress. Fact.

4. Dupi now embattled in court as well.

5. List of patent fails from Eylea, to Praluent, to genetic mice.

6. Leadership failed every product launch except Eylea (this is being kind).

About talent,

1. REGN HR group acknowledged poor recruiting practices and retention. Fact. HR told me this.

2. Before, during, post happy hours and sometimes at work, HR (among other functions) provides "lip service" to management - usually senior. HR knows this and allows it. Head of HR said this.

3. This company shows no respect for anything outside of ideas (patents), biologic science / substance - Len S. said this along with George Y.

Most of the posts here deal with topics mentioned above...so what isn't true? I know due to my 14 year tenure.

99% of posts here are true.
Click to expand...
 






anonymous said:
What isn't true?

1. Praluent is dead. Revenues are below $20MM. Is this what a few billion dollars of investment ROI looks like?

2. The US State Court of Delaware indicated more than one patent violations on Praluent. Fact.

3. Fourier data failed to impress. Fact.

4. Dupi now embattled in court as well.

5. List of patent fails from Eylea, to Praluent, to genetic mice.

6. Leadership failed every product launch except Eylea (this is being kind).

About talent,

1. REGN HR group acknowledged poor recruiting practices and retention. Fact. HR told me this.

2. Before, during, post happy hours and sometimes at work, HR (among other functions) provides "lip service" to management - usually senior. HR knows this and allows it. Head of HR said this.

3. This company shows no respect for anything outside of ideas (patents), biologic science / substance - Len S. said this along with George Y.

Most of the posts here deal with topics mentioned above...so what isn't true? I know due to my 14 year tenure.

99% of posts here are true.
Click to expand...
 












No. CV is different position and has nothing to do with the other divisions. Only the "essential" territories will be filled, and only when there is a Sanofi person missing from that "POD" will it be filled with a Regeneron. Otherwise, it could still be filled with Sanofi, and leave the Regeneron slot open.
 






Top Bottom
Back
Quote